Advanced injection molding technologies /
"This book covers the most recent and important developments in advanced injection molding technologies, such as intelligent process control; technology innovations and computer simulation for emerging special injection molding processes like ...
Turng, Lih-Sheng,editor. +1 more
core
Effects of different dosages/frequency of Xuebijing injection (a Chinese patent) for sepsis: a network meta-analysis of randomized controlled trials. [PDF]
Liu G +12 more
europepmc +1 more source
Effectiveness of Xuebijing injection for Sepsis: Overview of Systematic Reviews and Meta-analyses [PDF]
Yang-lin Shi +3 more
openaire +1 more source
Xuebijing injection combined with alprostadil in the treatment of diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis. [PDF]
Hao N, Liu Y, Guo L, Li W, Zhao P.
europepmc +1 more source
Safflower yellow in <i>Carthami Flos</i> is responsible for Xuebijing Injection-induced immediate hypersensitivity reaction through activating complement C3. [PDF]
Li W +8 more
europepmc +1 more source
Could Xuebijing Injection Reduce the Mortality of Severe Pneumonia Patients? A Systematic Review and Meta-Analysis. [PDF]
Wang J, Zhu J, Guo J, Wang Q.
europepmc +1 more source
[<i>Xuebijing</i> Injection in synergy with linezolid alleviates inflammatory injury in mice with MRSA pneumonia by inhibiting the Hla-NLRP3 pathway]. [PDF]
Yin M, Li R, Yang K, Jiao W, Liu X.
europepmc +1 more source
Efficacy and safety of Xuebijing combined with ulinastatin in the treatment of sepsis complicated by acute lung injury: a meta-analysis. [PDF]
Zhang T, Yuan Z.
europepmc +1 more source
A Clinical Study on the Effects and Mechanism of Xuebijing Injection () in Severe Pneumonia Patients [PDF]
ObjectiveTo observe the effects of Xuebijing Injection () in patients with severe pneumonia, and to explore the mechanism.MethodsEighty cases of severe pneumonia are randomly assigned to the Xuebijing treatment (forty cases) and the control group (forty ...
Guang-Tao Yan
exaly +4 more sources

